[go: up one dir, main page]

Tirmiara et al., 2019 - Google Patents

Formulation and evaluation of moringa seed oil nanoemulsion gel

Tirmiara et al., 2019

View PDF
Document ID
4616628680551795074
Author
Tirmiara N
Reveny J
Silalahi J
Publication year
Publication venue
Asian Journal of Pharmaceutical Research and Development

External Links

Snippet

Objective: The objective of this study was to formulate and evaluate the moringa seed oil (MSO) nanoemulsion gel using high-energy emulsification method. Methods: Nanoemulsion gel formulated by high-energy emulsification method using the comparison of surfactant …
Continue reading at www.ajprd.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

Similar Documents

Publication Publication Date Title
Salvia-Trujillo et al. In vitro and in vivo study of fucoxanthin bioavailability from nanoemulsion-based delivery systems: Impact of lipid carrier type
Li et al. Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: Influence of formulation parameters on polymethoxyflavone crystallization
Musa et al. Formulation optimization of palm kernel oil esters nanoemulsion-loaded with chloramphenicol suitable for meningitis treatment
Tirmiara et al. Formulation and evaluation of moringa seed oil nanoemulsion gel
Maha et al. Formulation and evaluation of miconazole nitrate nanoemulsion and cream
Sanjeewani et al. Formulation and characterization of virgin coconut oil (VCO) based emulsion
Paliwal et al. Formulation and characterization of topical nano emulgel of terbinafine
Mohsin et al. Formulation and stability of topical water in oil emulsion containing corn silk extract
Macedo et al. Micro-emultocrit technique: a valuable tool for determination of critical HLB value of emulsions
Atun et al. Formulation and characterization of quercitrin nanoemulsion isolated from dendropthoe falcata and its antioxidant activity test
Komal Self micro emulsifying drug delivery system-A
Jufri et al. Physical stability and antibacterial activity of black cumin oil (Nigella sativa L.) nanoemulsion gel
Pratiwi Novel antimicrobial activities of self-nanoemulsifying drug delivery system (SNEDDS) ethyl acetate fraction from Garcinia mangostana L. peels against Staphylococcus epidermidis: Design, optimization, and in vitro studies
Wang et al. Fabrication and characterization of a novel zein/pectin/pumpkin seed oil Pickering emulsion and the effects of myricetin on oxidation stability
Swain et al. Pharmaceutical drug delivery systems and vehicles
Thapa et al. Synthesis and characterization of a nanoemulsion system for solubility enhancement of poorly water soluble non-steroidal anti-inflammatory drugs
Nugraha et al. Preparation, characterization, and formulation of solid lipid nanoparticles lotion from mulberry roots (Morus alba L.)
Xie et al. Oil-gelling properties of soy lecithin fractions
Sari et al. Formulation and evaluation of red palm olein nanoemulsion
Szumała et al. Microemulsion delivery systems with low surfactant concentrations: optimization of structure and properties by glycol cosurfactants
Annisa et al. Formulation design and evaluation of hydrocortisone-loaded nanoemulsion and nanoemulsion gel for topical delivery
Katsouli et al. A Comparative Study of O/W Nanoemulsions Using Extra Virgin Olive or Olive‐Pomace Oil: Impacts on Formation and Stability
Desai et al. Screening of safflower oil microemulsion for enhancing bioavailability of lovastatin
Kiromah et al. Development and characterization of clove oil microemulsion
Sharma et al. Enhancement of solubility and stability of Celecoxib using microemulsion based topical formulation